Overview
Nicolas Tajeddine practices practicing medicine in Brussels, Belgium.
His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
He is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nicolas Tajeddine
Is Nicolas Tajeddine a top-rated expert for Glioblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Nicolas Tajeddine is classified as an Experienced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nicolas Tajeddine participate in research or clinical trials?
Yes. Nicolas Tajeddine has published 25 articles and abstracts on conditions like Glioblastoma. You can view a list of Nicolas Tajeddine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaMr. Tajeddine isExperienced. Learn about Astrocytoma.
- GlioblastomaMr. Tajeddine isExperienced. Learn about Glioblastoma.
- GliomaMr. Tajeddine isExperienced. Learn about Glioma.
- Gliomatosis CerebriMr. Tajeddine isExperienced. Learn about Gliomatosis Cerebri.